Regulation of Histone Acetylation and Transcription by INHAT, a Human Cellular Complex Containing the Set Oncoprotein

[1]  R. Goodman,et al.  Histone Binding Protein RbAp48 Interacts with a Complex of CREB Binding Protein and Phosphorylated CREB , 2000, Molecular and Cellular Biology.

[2]  Y. Nakatani,et al.  ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation , 2000, Nature.

[3]  R. Roeder,et al.  HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. , 2000, Molecular cell.

[4]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[5]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[6]  J. T. Kadonaga,et al.  Biochemical Analysis of Distinct Activation Functions in p300 That Enhance Transcription Initiation with Chromatin Templates , 1999, Molecular and Cellular Biology.

[7]  J. T. Kadonaga,et al.  The “Dark Side” of Chromatin Remodeling Repressive Effects on Transcription , 1999, Cell.

[8]  R. Evans,et al.  Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase , 1999, Cell.

[9]  J. Pevsner,et al.  Correction to “Modulation of oncogenic potential by alternative gene use in human prostate cancer” , 1999, Nature Network Boston.

[10]  S. Dimitrov,et al.  Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. , 1999, Biochemistry.

[11]  K. Nagata,et al.  Functional domains of template-activating factor-I as a protein phosphatase 2A inhibitor. , 1999, Biochemical and biophysical research communications.

[12]  L. Freedman.  Increasing the Complexity of Coactivation in Nuclear Receptor Signaling , 1999, Cell.

[13]  J. Pevsner,et al.  Modulation of oncogenic potential by alternative gene use in human prostate cancer , 1999, Nature Medicine.

[14]  R. Evans,et al.  A Viral Mechanism for Inhibition of p300 and PCAF Acetyltransferase Activity , 1999, Cell.

[15]  L. Kedes,et al.  Regulation of Histone Acetyltransferases p300 and PCAF by the bHLH Protein Twist and Adenoviral Oncoprotein E1A , 1999, Cell.

[16]  C. Allis,et al.  Overlapping but Distinct Patterns of Histone Acetylation by the Human Coactivators p300 and PCAF within Nucleosomal Substrates* , 1999, The Journal of Biological Chemistry.

[17]  K. Nagata,et al.  Template Activating Factor-I Remodels the Chromatin Structure and Stimulates Transcription from the Chromatin Template* , 1998, The Journal of Biological Chemistry.

[18]  J. Girault,et al.  Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A , 1998, Nature.

[19]  Julie A. Brown,et al.  HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  William Arbuthnot Sir Lane,et al.  Rabbit beta-globin is extended beyond its UGA stop codon by multiple suppressions and translational reading gaps. , 1998, Biochemistry.

[21]  Andrew J. Bannister,et al.  The acetyltransferase activity of CBP stimulates transcription , 1998, The EMBO journal.

[22]  K. Nagata,et al.  Cellular localization and expression of template-activating factor I in different cell types. , 1998, Experimental cell research.

[23]  S. Berger,et al.  Repression of GCN5 Histone Acetyltransferase Activity via Bromodomain-Mediated Binding and Phosphorylation by the Ku–DNA-Dependent Protein Kinase Complex , 1998, Molecular and Cellular Biology.

[24]  K. Struhl.  Histone acetylation and transcriptional regulatory mechanisms. , 1998, Genes & development.

[25]  C. Glass,et al.  Transcription factor-specific requirements for coactivators and their acetyltransferase functions. , 1998, Science.

[26]  Bruce Stillman,et al.  Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase , 1998, Current Biology.

[27]  L. Kedes,et al.  Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.

[28]  M. Grunstein.  Histone acetylation in chromatin structure and transcription , 1997, Nature.

[29]  T. Richmond,et al.  Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.

[30]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[31]  R. Evans,et al.  Nuclear Receptors in Sicily: All in the Famiglia , 1997, Cell.

[32]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[33]  G. Pasternack,et al.  Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. , 1996, Molecular biology of the cell.

[34]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[35]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[36]  B. Howard,et al.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.

[37]  Z. Damuni,et al.  The Myeloid Leukemia-associated Protein SET Is a Potent Inhibitor of Protein Phosphatase 2A (*) , 1996, The Journal of Biological Chemistry.

[38]  A. Wolffe,et al.  Histone Deacetylase--A Regulator of Transcription , 1996, Science.

[39]  A. Murray,et al.  Members of the NAP/SET family of proteins interact specifically with B- type cyclins , 1995, The Journal of cell biology.

[40]  K. Yano,et al.  Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[42]  T. Copeland,et al.  Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia. , 1994, The Journal of biological chemistry.

[43]  D. S. Coffey,et al.  A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. , 1993, Cancer research.

[44]  Marieke,et al.  Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene , 1992, Molecular and cellular biology.

[45]  D. Baltimore,et al.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor , 1988, Cell.

[46]  V. Jackson.  Studies on histone organization in the nucleosome using formaldehyde as a reversible cross-linking agent , 1978, Cell.